Early stage epithelial ovarian cancers: a study of morphologic prognostic factors

Pathol Res Pract. 2013 Jun;209(6):359-64. doi: 10.1016/j.prp.2013.03.009. Epub 2013 Mar 30.

Abstract

We intended to reevaluate the morphologic prognostic factors for early-stage ovarian carcinomas. We reviewed 111 patients diagnosed with early-stage ovarian cancer who had undergone primary surgery at Hacettepe Hospital between 1984 and 2001, using diagnostic criteria from the WHO-2003 classification. We applied the Universal grading system suggested by Shimizu/Silverberg and noted FIGO-stage, histotype, tumor size, bilaterality, and endometriosis. These features were compared with each other and survival. The survival analysis was carried out by Kaplan-Meier curves. Of the cases, 52 were reclassified as 'borderline tumor' or 'cystadenoma with borderline foci' and 59 as 'invasive carcinoma'. FIGO-stage and mitotic count were significant for survivals of 59 patients with cancer. Mitotic index was also significant for the probability of metastasis. The patients with stage-II cancer had 5.65 times more risk of recurrence than stage-I cancer. The 5-year overall and disease-free survivals rates were 90.6% and 87.5% for stage-I, 54.7% and 39.3% for stage-II, respectively. Universal grade did not reach statistical significance for survivals but it was related to FIGO-stage significantly. In conclusion, FIGO-stage is the most reliable prognosticator. Although prognostic value of universal grade is not significant, mitotic count may provide important prognostic information for early-stage ovarian carcinomas.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Carcinoma / mortality
  • Carcinoma / pathology*
  • Carcinoma / surgery
  • Carcinoma, Ovarian Epithelial
  • Chi-Square Distribution
  • Cystadenoma / mortality
  • Cystadenoma / pathology*
  • Cystadenoma / surgery
  • Disease-Free Survival
  • Endometriosis / pathology
  • Female
  • Hospitals, University
  • Humans
  • Kaplan-Meier Estimate
  • Middle Aged
  • Mitotic Index
  • Multivariate Analysis
  • Neoplasm Grading
  • Neoplasm Invasiveness
  • Neoplasm Staging
  • Neoplasms, Glandular and Epithelial / mortality
  • Neoplasms, Glandular and Epithelial / pathology*
  • Neoplasms, Glandular and Epithelial / surgery
  • Ovarian Neoplasms / mortality
  • Ovarian Neoplasms / pathology*
  • Ovarian Neoplasms / surgery
  • Predictive Value of Tests
  • Proportional Hazards Models
  • Risk Factors
  • Time Factors
  • Treatment Outcome
  • Tumor Burden
  • Turkey